Heart Disease

Clinical trials slated for choelsterol drug

Published in Blood Weekly, November 4th, 2004

Danish company LifeCycle Pharma has announced the initiation of clinical trials on a new tablet formulation of fenofibrate, a cholesterol-lowering drug.

"We expect to file for market authorization of our superior fenofibrate product in 2005, providing LifeCycle Pharma with its first launch," said Jan Møller Mikkelsen, president and CEO of LifeCycle Pharma. "LifeCycle Pharma has several products in clinical trials, but fenofibrate is the first that we advance into clinical trials independently of a partner," said Mikkelsen.

"In less than 12 months, we have developed a superior fenofibrate tablet formulation, from idea to clinical trials," said Michael...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-11-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry